richard lipton, md, director, montefiore headache center; edwin s. lowe professor and vice chairman of neurology, albert einstein college of medicine.
.
.
�such figures underline how vital it is that the government supports the nhs to improve waiting times this year.�
.
.
.
.
.: "fremanezumab for the preventive treatment of chronic migraine."
.